World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 March 2021
Main ID:  NCT02217657
Date of registration: 14/08/2014
Prospective Registration: No
Primary sponsor: Klinikum der Universitaet Muenchen
Public title: SmartTouch Catheter for Left Anterior Line - SmarT Line Study
Scientific title: "Bidirectional Conduction Block of Left Atrial Anterior Line in Patients With Left Atrial Ablation - Reduction of RF Applications Using the Thermocool SmartTouch Contact Force Sensing Catheter
Date of first enrolment: August 2013
Target sample size: 75
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02217657
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name:     Heidi Estner, MD
Address: 
Telephone:
Email:
Affiliation:  Munich University Clinic, Campus Großhadern
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with symptomatic atrial fibrillation and additional substrate modification or
perimitral flutter

- Patients with persistent atrial fibrillation

- Patients with perimitral flutter

- Patients with recurrence after a circumferential PV isolation procedure

- Patients with paroxysmal atrial fibrillation and AF episodes lasting > 7 days

- Patients (>18 und <80 Jahre)

Exclusion Criteria:

- moderate to severe valvular heart disease,

- congenital heart disease

- reduced left ventricular function (ejection fraction <35%)

- any reversible cause for atrial fibrillation (e.g. hyperthyroidism)

- intracardiac thrombi documented by transesophageal echocardiography

- myocardial infarction within 3 months, cardiac surgery in the previous three months



Age minimum: 18 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Persistent Atrial Fibrillation
Intervention(s)
Device: Thermocool Smart Touch Catheter
Primary Outcome(s)
Duration of total RF application until bidirectional conduction block across the anterior line is achieved (including a waiting period of 30 minutes) [Time Frame: 30 minutes]
Secondary Outcome(s)
Achievement of primary endpoint (bidirectional conduction block at an anterior line) [Time Frame: 6 months]
Secondary ID(s)
MucM001-13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history